Moreover, determination of the relationship between SH3D21 expression and clinical characteristics of HCC patients revealed that SH3D21 was highly expressed in females (P = 0.0099) and increased with the elevation of tumor T-stage (Fig 1B), histological grading (Fig 1C) and clinical stage (Fig 1D). The gene discussed is MNMIP1; the disease is neoplasm.